GL
GLHL.PA Amundi S&P World Health Care Screened UCITS ETF Acc
- EUR
No recent price
- Total assets
- 1.30B
- Expense ratio
- 0.19%
- Dividend yield
- -
- 1-year return
- -
- Holdings
- 10
- Since
- 2022
Fund data as reported by the issuer, updated Nov 7, 2026. Total assets are in the fund's base currency.
What does GLHL.PA invest in?
- Largest sector: Healthcare (100.0%)
- Top 3 holdings: 27.0% of the fund
Top holdings
- Eli Lilly and Company 12.47%
- AbbVie Inc 8.77%
- Merck & Company Inc 5.75%
- AstraZeneca PLC 4.74%
- Novartis AG 4.72%
Amundi S&P World Health Care Screened UCITS ETF Acc performance
Return figures of Amundi S&P World Health Care Screened UCITS ETF Acc are not available yet.
GLHL.PA price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Amundi S&P World Health Care Screened UCITS ETF Acc top holdings
56.1% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Eli Lilly and Company LLY.US | Healthcare | United States | 12.47% |
| AbbVie Inc ABBV.US | Healthcare | United States | 8.77% |
| Merck & Company Inc MRK.US | Healthcare | United States | 5.75% |
| AstraZeneca PLC AZN.LSE | Healthcare | United Kingdom | 4.74% |
| Novartis AG NOVN.SW | Healthcare | Switzerland | 4.72% |
| UnitedHealth Group Incorporated UNH.US | Healthcare | United States | 4.46% |
| Amgen Inc AMGN.US | Healthcare | United States | 4.15% |
| Roche Holding AG ROP.SW | Healthcare | Switzerland | 3.90% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 3.65% |
| Thermo Fisher Scientific Inc TMO.US | Healthcare | United States | 3.52% |
GLHL.PA sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
Company size
- Mega cap33.9%
- Big cap56.1%
- Medium cap10.6%
- Small cap0.2%
Amundi S&P World Health Care Screened UCITS ETF Acc fund profile
- Fund name
- Amundi S&P World Health Care Screened UCITS ETF Acc
- Ticker
- GLHL.PA
- Exchange
- Euronext Paris
- Issuer
- Amundi
- Index tracked
- -
- Category
- -
- Inception date
- Sep 20, 2022
- Trading currency
- EUR
- Expense ratio
- 0.19%